S2Medical AB (S2ME)

Currency in SEK
0.013
0.000(0.00%)
Closed·
S2ME Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Earnings results expected in 12 days
S2ME is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.0130.013
52 wk Range
0.0050.047
Key Statistics
Prev. Close
0.013
Open
0.013
Day's Range
0.013-0.013
52 wk Range
0.005-0.047
Volume
861.89K
Average Volume (3m)
10.5M
1-Year Change
-58.34%
Book Value / Share
0.02
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
S2ME Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Impressive gross profit margins

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Buy
Moving Averages
Strong Buy

S2Medical AB Company Profile

S2Medical AB (publ) develops, produces, and sells wound healing products for burns and chronic wounds in Sweden. It offers Epiprotect 2117, a synthetic allograft/xenograft substitute; Epiprotect Ulcer, a wound dressing consisting of a thin film of biosynthetic cellulose polymer intended to be used as a protective barrier for superficial wounds and deep wounds that have breached the dermis, as well as used as a temporary coverage for deep extensive wounds before transplantation or other surgical intervention. The company also provides washable, durable, waterproof, and self-adhesive bandages under the INSTABIND brand name, as well as NO SMELL, a perfume-free odour remover; BIOPAD, an ivory-white soft sponge; and INSTAQRETT, a sterile mechanical debridement tool for, among other things, multi-resistant Staphylococci. In addition, it offers IvaQ, CE-marked negative pressure wound therapy; Instagraft, designed to make advanced skin transplantation; ADMERCIN, next-generation antimicrobial peptide technology; Symbiovance, peptide-based functional skincare; Eyracure, a patented light-activated peptide technology that repairs damaged hair at the molecular level; and Eiratex, advanced biosynthetic polymer for next-generation wound healing applications. Further, the company operates the wound healing center under the S2Clinic name. The company was incorporated in 2013 and is headquartered in Linköping, Sweden.

Compare S2ME to Peers and Sector

Metrics to compare
S2ME
Peers
Sector
Relationship
P/E Ratio
2.3x−2.8x−0.5x
PEG Ratio
0.020.050.00
Price/Book
0.6x1.6x2.6x
Price / LTM Sales
0.7x1,565.9x3.3x
Upside (Analyst Target)
-0.0%43.4%
Fair Value Upside
Unlock−1.8%7.1%Unlock

Earnings

Latest Release
May 30, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

S2ME Income Statement

FAQ

What Stock Exchange Does S2Medical Trade On?

S2Medical is listed and trades on the Stockholm Stock Exchange stock exchange.

What Is the Stock Symbol for S2Medical?

The stock symbol for S2Medical is "S2ME."

What Is the S2Medical Market Cap?

As of today, S2Medical market cap is 10.98M.

What Is S2Medical's Earnings Per Share (TTM)?

The S2Medical EPS (TTM) is 0.01.

When Is the Next S2Medical Earnings Date?

S2Medical will release its next earnings report on 21 Aug 2025.

From a Technical Analysis Perspective, Is S2ME a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has S2Medical Stock Split?

S2Medical has split 1 times.

How Many Employees Does S2Medical Have?

S2Medical has 7 employees.

What is the current trading status of S2Medical (S2ME)?

As of 10 Aug 2025, S2Medical (S2ME) is trading at a price of 0.01, with a previous close of 0.01. The stock has fluctuated within a day range of 0.01 to 0.01, while its 52-week range spans from 0.01 to 0.05.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.